JP2013511966A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013511966A5 JP2013511966A5 JP2012540419A JP2012540419A JP2013511966A5 JP 2013511966 A5 JP2013511966 A5 JP 2013511966A5 JP 2012540419 A JP2012540419 A JP 2012540419A JP 2012540419 A JP2012540419 A JP 2012540419A JP 2013511966 A5 JP2013511966 A5 JP 2013511966A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion polypeptide
- seq
- amino acid
- domain
- polypeptide according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009047243A DE102009047243A1 (de) | 2009-11-27 | 2009-11-27 | Monospezifische Polypeptidreagenzien |
| DE102009047243.6 | 2009-11-27 | ||
| PCT/EP2010/068134 WO2011064257A2 (de) | 2009-11-27 | 2010-11-24 | Monospezifische polypeptidreagenzien |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013511966A JP2013511966A (ja) | 2013-04-11 |
| JP2013511966A5 true JP2013511966A5 (enExample) | 2014-01-09 |
Family
ID=43589669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012540419A Pending JP2013511966A (ja) | 2009-11-27 | 2010-11-24 | 単一特異性ポリペプチド試薬 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US9163079B2 (enExample) |
| EP (1) | EP2504359B1 (enExample) |
| JP (1) | JP2013511966A (enExample) |
| AU (1) | AU2010323144B2 (enExample) |
| CA (1) | CA2782016C (enExample) |
| DE (1) | DE102009047243A1 (enExample) |
| DK (1) | DK2504359T3 (enExample) |
| WO (1) | WO2011064257A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007145840A2 (en) | 2006-06-13 | 2007-12-21 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| AU2008209482B2 (en) | 2007-01-24 | 2014-05-01 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for diagnosing and treating cancer |
| CA2729602A1 (en) | 2008-07-08 | 2010-01-14 | Oncomed Pharmaceuticals, Inc. | Notch1 receptor binding agents and methods of use thereof |
| DE102009047243A1 (de) * | 2009-11-27 | 2011-06-01 | Orgentec Diagnostika Gmbh | Monospezifische Polypeptidreagenzien |
| WO2013156054A1 (en) * | 2012-04-16 | 2013-10-24 | Universität Stuttgart | The igm and ige heavy chain domain 2 as covalently linked homodimerization modules for the generation of fusion proteins with dual specificity |
| US20170023576A1 (en) * | 2014-04-04 | 2017-01-26 | Oncomed Pharmaceuticals, Inc. | Notch3 antibodies and uses thereof |
| ES2975750T3 (es) * | 2016-08-26 | 2024-07-12 | Sanofi Sa | Anticuerpos multiespecíficos que facilitan el emparejamiento selectivo de las cadenas ligeras |
| US11124562B2 (en) | 2016-10-28 | 2021-09-21 | Washington University | Anti-ApoE antibodies |
| US12497439B2 (en) | 2019-01-07 | 2025-12-16 | Thomas Jefferson University | Multi-functional fusion proteins and uses thereof |
| WO2020260368A1 (en) | 2019-06-24 | 2020-12-30 | Universität Stuttgart | Tnfr2 agonists with improved stability |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994009817A1 (en) | 1992-11-04 | 1994-05-11 | City Of Hope | Novel antibody construct |
| US6015662A (en) | 1996-01-23 | 2000-01-18 | Abbott Laboratories | Reagents for use as calibrators and controls |
| EP0938506B1 (en) * | 1996-07-16 | 2003-11-05 | Plückthun, Andreas, Prof. Dr. | Immunoglobulin superfamily domains and fragments with increased solubility |
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ，インコーポレイティド | 人工抗体ポリペプチド |
| US6151296A (en) | 1997-06-19 | 2000-11-21 | Qualcomm Incorporated | Bit interleaving for orthogonal frequency division multiplexing in the transmission of digital signals |
| JP2003501096A (ja) * | 1999-06-07 | 2003-01-14 | ネオルクス コーポレイション | ストレプトアビジン発現性遺伝子融合およびその使用方法 |
| DE10001372A1 (de) | 2000-01-14 | 2001-08-02 | Deutsches Krebsforsch | Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| AU2003210060B2 (en) | 2002-03-22 | 2010-02-25 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| WO2006117782A2 (en) * | 2005-05-04 | 2006-11-09 | Quark Pharmaceuticals, Inc. | Recombinant antibodies against cd55 and cd59 and uses thereof |
| ES2569917T3 (es) * | 2005-06-21 | 2016-05-13 | Xoma (Us) Llc | Anticuerpos y fragmentos de los mismos que se unen a IL-1beta |
| ATE452913T1 (de) | 2005-08-26 | 2010-01-15 | Pls Design Gmbh | Bivalente igy antikörperkonstrukte für diagnostische und therapeutische anwendungen |
| JP5102772B2 (ja) | 2005-11-29 | 2012-12-19 | ザ・ユニバーシティ・オブ・シドニー | デミボディ：二量体化活性化治療剤 |
| EP1954187A1 (en) | 2005-12-01 | 2008-08-13 | Atcor Medical Pty Ltd | A method of estimating pulse wave velocity |
| EP1996716B1 (en) | 2006-03-20 | 2011-05-11 | The Regents of the University of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
| GB0614780D0 (en) * | 2006-07-25 | 2006-09-06 | Ucb Sa | Biological products |
| CA2682605A1 (en) * | 2007-04-18 | 2008-10-30 | Zymogenetics, Inc. | Single chain fc, methods of making and methods of treatment |
| WO2008131252A1 (en) * | 2007-04-20 | 2008-10-30 | Invista Technologies S.A.R.L. | Compact continuous over end take-off (oeto) creel with tension control |
| EP2170951A2 (en) * | 2007-05-31 | 2010-04-07 | Genmab A/S | Recombinant non glycosylated monovalent half-antibodies obtained by molecular engineering |
| EP2116555A1 (en) | 2008-05-08 | 2009-11-11 | Bayer Schering Pharma Aktiengesellschaft | Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma |
| DE102009047243A1 (de) * | 2009-11-27 | 2011-06-01 | Orgentec Diagnostika Gmbh | Monospezifische Polypeptidreagenzien |
-
2009
- 2009-11-27 DE DE102009047243A patent/DE102009047243A1/de not_active Withdrawn
-
2010
- 2010-11-24 EP EP10798744.8A patent/EP2504359B1/de active Active
- 2010-11-24 AU AU2010323144A patent/AU2010323144B2/en not_active Ceased
- 2010-11-24 JP JP2012540419A patent/JP2013511966A/ja active Pending
- 2010-11-24 WO PCT/EP2010/068134 patent/WO2011064257A2/de not_active Ceased
- 2010-11-24 US US13/512,206 patent/US9163079B2/en active Active
- 2010-11-24 CA CA2782016A patent/CA2782016C/en active Active
- 2010-11-24 DK DK10798744.8T patent/DK2504359T3/da active
-
2015
- 2015-09-09 US US14/848,636 patent/US9815891B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2637667T3 (es) | Un anticuerpo que se une específicamente al factor de crecimiento insulinoide 1 | |
| ES3013602T3 (en) | Antigen binding molecules and methods of use thereof | |
| ES2643640T3 (es) | Agentes para tratamiento de enfermedad | |
| EP3670534A3 (en) | Human fgf receptor and beta-klotho binding proteins | |
| HRP20201191T1 (hr) | Mutirani multispecifični fab fragmenti antitijela | |
| KR20160014010A (ko) | 신규 항체 | |
| BRPI0607315A2 (pt) | polinucleotìdeo isolado, vetor de expressão, composição, método de produzir uma molécula de ligação de antìgeno, molécula de ligação de antìgeno e o uso da mesma-, método para detectar in vivo ou in vitro a presença de egfr em uma amostra, célula hospedeira engendrada, composição farmacêutica e o uso da mesma | |
| AR077088A1 (es) | Proteinas biespecificas de union a antigeno | |
| EA201490262A1 (ru) | Модифицированные белки и пептиды | |
| DK2504359T3 (da) | Monospecifikke polypeptidreagenser | |
| Macpherson et al. | Isolation of antigen-specific, disulphide-rich knob domain peptides from bovine antibodies | |
| CN109661235B (zh) | 抗原结合分子及其使用的方法 | |
| RU2018141360A (ru) | Contorsbody - одноцепочечный связывающий мишень агент | |
| RU2012143798A (ru) | Биспецифические антитела | |
| RU2014102007A (ru) | Методы предсказания, обнаружения и уменьшения неспецифической интерференции белков в способах анализа с использованием одиночных вариабельных доменов иммуноглобулинов | |
| RU2015152077A (ru) | Тримерные антигенсвязывающие молекулы | |
| Tigue et al. | MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential | |
| Nilvebrant et al. | Selection and in vitro characterization of human CD44v6‐binding antibody fragments | |
| JP7084057B2 (ja) | 新規抗ｐａｄ２抗体 | |
| ATE535546T1 (de) | Humane monoklonale antikörper, die spezifisch an ifg-ii binden | |
| Miura et al. | Nucleotide-dependent behavior of single molecules of cytoplasmic dynein on microtubules in vitro | |
| EP3036259B1 (en) | Antibodies specifically binding to her3 | |
| TWI593967B (zh) | 二級抗體所辨識之抗原決定位及其用途 | |
| RU2020112751A (ru) | Отличные от человека животные, у которых экспрессируется гуманизированный комплекс c1q | |
| CN102863529A (zh) | 一种vegf单抗及包含该单抗的骨折愈合评价抗体芯片 |